Fibrinogen mediates bladder cancer cell migration in an ICAM-1-dependent pathway

Thrombosis and Haemostasis

Volumn 89, Issue 6, 2003, Pages 1089-1097

  Roche, Yann ^a   Pasquier, Dominique ^a   Rambeaud, Jean Jacques ^a   Seigneurin, Daniel ^a   Duperray, Alain ^a  

^a INSTITUT ALBERT BONNIOT   (France)

Author keywords

Cell migration; Fibrinogen; ICAM 1; Metastasis; Tumor invasion

Indexed keywords

FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2D5; MONOCLONAL ANTIBODY 3D6; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER GRADING; CANCER MODEL; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; FOCAL ADHESION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; LEUKOCYTE MIGRATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN IMMOBILIZATION; PROTEIN INTERACTION; TRANSITIONAL CELL CARCINOMA;

EID: 0038489134     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613412     Document Type: Article

References (32)

1. Liotta LA. Tumor invasion and metastases - Role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 1986;46(1):1-7.
2. Brown LF, Van De Water L, Harvey VS, Dvorak HF. Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma. Am J Pathol 1988;130(3):455-65.
3. Dvorak HF, Senger DR, Dvorak AM. Fibrin as a component of the tumor stroma: Origins and biological significance. Cancer Metastasis Rev 1983;2(1):41-73.
4. Dvorak HF, Nagy JA, Berse B, et al. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann N Y Acad Sci 1992;667:101-11.
5. Dejana E, Languino LR, Polentarutti N, Balconi G, Ryckewaert JJ, Larrieu MJ, et al. Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest 1985;75(1):11-8.
6. Altieri DC, Mannucci PM, Capitanio AM. Binding of fibrinogen to human monocytes. J Clin Invest 1986;78(4):968-76.
7. Hart IR, Goode NT, Wilson RE. Molecular aspects of the metastatic cascade. Biochim Biophys Acta 1989;989(1):65-84.
8. Languino LR, Plescia J, Duperray A, Brian AA, Plow EF, Geltosky JE, et al. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell 1993;73(7):1423-34.
9. Languino LR, Duperray A, Joganic KJ, Fornaro M, Thornton GB, Altieri DC. Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc Natl Acad Sci U S A 1995;92(5):1505-9.
10. Sans E, Delachanal E, Duperray A. Analysis of the roles of ICAM-1 in neutrophil transmigration using a reconstituted mammalian cell expression model: Implication of ICAM-1 cytoplasmic domain and Rho-dependent signaling pathway. J Immunol 2001;166(1):544-51.
11. Jackson AM, Alexandrov AB, Prescott S, James K, Chisholm GD. Expression of adhesion molecules by bladder cancer cells: Modulation by interferon-gamma and tumour necrosis factor-alpha. J Urol 1992;148(5):1583-6.
12. Miele ME, Bennett CF, Miller BE, Welch DR. Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides. Exp Cell Res 1994;214(1):231-41.
13. Palumbo JS, Potter JM, Kaplan LS, Talmage K, Jackson DG, Degen JL. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res 2002;62(23):6966-72.
14. Engvall E, Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer 1977;20(1):1-5.
15. Rigby CC, Franks LM. A human tissue culture cell line from a transitional cell tumour of the urinary bladder: Growth, chromosome pattern and ultrastructure. Br J Cancer 1970;24(4):746-54.
16. O'Toole C, Perlmann P, Unsgaard B, Moberger G, Edsmyr F. Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy. Int J Cancer 1972;10(1):77-91.
17. Nayak SK, O'Toole C, Price ZH. A cell line from an anaplastic transitional cell carcinoma of human urinary bladder. Br J Cancer 1977;35(2):142-51.
18. O'Toole C, Price ZH, Ohnuki Y, Unsgaard B. Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma. Br J Cancer 1978;38(1):64-76.
19. Marshall CJ, Franks LM, Carbonell AW. Markers of neoplastic transformation in epithelial cell lines derived from human carcinomas. J Natl Cancer Inst 1977;58(6):1743-51.
20. Perissel B, Benkhalifa M, Taillandier J, et al. Karyotype and FISH analysis of a newly established cell line derived from human bladder carcinoma. Cancer Genet Cytogenet 1993;67:101-7.
21. Mialhe A, Louis J, Montlevier S, et al. Expression of E-cadherin and alpha-, beta- and gamma-catenins in human bladder carcinomas: Are they good prognostic factors? Invasion Metastasis 1997;17(3):124-37.
22. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52(11):2745-56.
23. Aktories K, Braun U, Rosener S, Just I, Hall A. The rho gene product expressed in E. coli is a substrate of botulinum ADP-ribosyltransferase C3. Biochem Biophys Res Commun 1989;158(1):209-13.
24. Hermanek P, Sobin LH. UICC, TNM Classification of Malignant Tumors. Paris, Springer 1988.
25. Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. International Histological Classification of Tumours, 10. Geneva: World Health Organisation 1973.
26. Herrick S, BlancBrude O, Gray A, Laurent G. Fibrinogen. Int J Biochem Cell Biol 1999;31(7):741-6.
27. Duperray A, Languino LR, Plescia J, et al. Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging. J Biol Chem 1997;272(1):435-41.
28. Nobes CD, Hall A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol 1999;144(6):1235-44.
29. Etienne S, Adamson P, Greenwood J, Strosberg AD, Cazaubon S, Couraud PO. ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells. J Immunol 1998;161(10):5755-61.
30. Palumbo JS, Kombrinck KW, Drew AF, et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 2000;96(10):3302-9.
31. Drew AF, Liu H, Davidson JM, Daugherty CC, Degen JL. Wound-healing defects in mice lacking fibrinogen. Blood 2001;97(12):3691-8.
32. Nagaoka T, Kaburagi Y, Hamaguchi Y, et al. Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression. Am J Pathol 2000;157(1):237-47.